Incyte

Incyte in Fortune Rankings

Updated:10/21/26
Country/Territory:U.S.
Headquarters:Wilmington, Del.
Industry:Pharmaceuticals
CEO:William J. Meury
Website:https://www.incyte.com

Ticker:INCY
Company type:Public
Revenues ($M):$5,361
Profits ($M):$1,432
Market value ($M):$24,597
Number of employees:2,844

Figures are for latest twelve months ended on or before April 30, 2026. Market value as of Sept. 30, 2026.

$ millions% change
Revenues ($M):$5,141.221.2%
Profits ($M):$1,286.73845%
Assets ($M):$6,958-
Total Stockholder Equity ($M):$5,167.5-

Profit as % of Revenues:25%
Profits as % of Assets:18.5%
Profits as % of Stockholder Equity:24.9%

Earnings Per Share ($):6.40
EPS % Change (from prior fiscal year):4173.3%
EPS % Change (5 year annual rate):-
EPS % Change (10 year annual rate):71%

Total Return to Investors (last year):43%
Total Return to Investors (5 year, annualized):2.6%
Total Return to Investors (10 year, annualized):-0.9%

Revenue 3 Yr Growth Rank:97
Revenue 3 Yr Annual Growth Rate:15.6%
EPS 3 Yr Growth Rank:40
EPS 3 Yr Annual Growth Rate:69.5%
Total Return 3 Yr Rank:79
Total Return 3 Yr Annual Rate:22.1%
Beat S&P 500 3 Yr Return:yes
Current Streak:1
Years on List:1
Sector:Health Care

Total return for the period ended June 30, 2026.

Incyte stock chart

Incyte in Fortune Rankings

View the Full List

View the Full List